Generated by GPT-5-mini| Patient Safety First | |
|---|---|
| Name | Patient Safety First |
| Formation | 2007 |
| Founder | National Patient Safety Agency |
| Type | Initiative |
| Headquarters | United Kingdom |
| Region served | National Health Service |
| Purpose | Patient safety improvement |
Patient Safety First Patient Safety First was a United Kingdom–based initiative launched to reduce avoidable harm in clinical care and to promote safer practices across hospitals, community services, and primary care. It sought to align professional bodies, regulatory agencies, and frontline organizations to accelerate uptake of evidence-based interventions and change management strategies. The programme emphasised practical tools, education, and measurement to lower rates of adverse events and strengthen patient-centred care.
Patient Safety First united stakeholders including the National Patient Safety Agency, Department of Health (United Kingdom), National Health Service, General Medical Council, and representative organisations such as Royal College of Nursing, Royal College of Physicians, and British Medical Association. The initiative produced toolkits, safety briefs, and campaign materials that addressed high-impact areas such as medication safety, venous thromboembolism prevention, and reduction of healthcare-associated infections like Clostridioides difficile infection and methicillin-resistant Staphylococcus aureus. It drew on guidance from bodies including National Institute for Health and Care Excellence and international frameworks from the World Health Organization and Institute for Healthcare Improvement.
Patient Safety First emerged following policy responses to high-profile reports and inquiries such as the Shipman Inquiry, the Bristol Royal Infirmary Inquiry, and evaluations by the Healthcare Commission. These events prompted the Department of Health (United Kingdom) and the National Patient Safety Agency to coordinate a national safety programme in the mid-2000s, aligned with international patient safety movements like the WHO Patient Safety initiatives and lessons from Institute of Medicine reports. The launch consolidated preexisting campaigns from professional colleges, patient advocacy groups including Patients Association, and regulatory guidance from the Care Quality Commission.
Patient Safety First emphasised several core principles drawn from quality improvement and clinical governance literature. These included standardisation through checklists inspired by the World Health Organization surgical safety checklist, risk-reduction bundles parallel to programmes from the Institute for Healthcare Improvement, and systems-based approaches promoted by James Reason's Swiss cheese model. Practices promoted included medication reconciliation influenced by guidance from the Royal Pharmaceutical Society, escalation protocols reflecting British Medical Association recommendations, and use of early warning scoring systems akin to the National Early Warning Score used in acute care. The initiative encouraged interprofessional collaboration between clinicians from organisations such as Royal College of Surgeons, Royal College of Anaesthetists, and College of Emergency Medicine.
Implementation modalities targeted acute hospitals, primary care practices, and community services across regions governed by NHS England and devolved administrations like NHS Scotland and NHS Wales. Tactics included local safety congresses co-delivered with Hospital Trusts, dissemination of Clinical Effectiveness Unit materials parallel to work by the National Institute for Health and Care Excellence, and adoption of training modules used by Health Education England and regional deaneries. Interventions were embedded through governance routes such as Clinical Commissioning Groups oversight, trust-level patient safety committees, and professional revalidation processes administered by the General Medical Council and Nursing and Midwifery Council.
Measurement strategies stressed process and outcome metrics familiar to national reporting systems. These included rates of hospital-acquired Clostridioides difficile infection, drug-related adverse events, venous thromboembolism incidence following guidance from National Institute for Health and Care Excellence, and surgical complication rates monitored alongside data sources used by the Health and Social Care Information Centre (now NHS Digital). The programme advocated patient safety dashboards and use of audits as used in clinical audit traditions promoted by the Royal College of Physicians and Royal College of Surgeons. Evaluations cited reductions in target harms in some localities, although effect sizes varied and were often linked to concurrent national initiatives such as financial incentives from Payment by Results reforms and regulatory changes by the Care Quality Commission.
Critics pointed to issues familiar across national improvement campaigns: attribution of outcomes in the presence of overlapping programmes like Clean Your Hands campaigns, sustainability of change beyond pilot sites, and variability between NHS Trusts in capacity for improvement. Some commentators from bodies including Kings Fund and Nuffield Trust noted limited independent evaluation, reliance on voluntary uptake, and tensions between top-down mandates and frontline ownership. Others raised concerns about measurement focus—overemphasis on easily quantifiable indicators at the expense of patient experience metrics championed by patient advocacy groups such as Healthwatch and the Patients Association. Operational constraints such as workforce shortages highlighted by reports from Royal College of Nursing and funding pressures described in analyses by Institute for Fiscal Studies further complicated implementation.
Category:Patient safety Category:Healthcare in the United Kingdom